Down-regulation of transcobalamin receptor TCblR/CD320 by siRNA inhibits cobalamin uptake and proliferation of cells in culture

Experimental Cell Research

Volumn 317, Issue 11, 2011, Pages 1603-1607

  Lai, Shao Chiang ^a   Nakayama, Yasumi ^a   Sequeira, Jeffrey M ^a   Quadros, Edward V ^a  

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

Author keywords

Cobalamin; SiRNA; TCblR CD320; Transcobalamin receptor

Indexed keywords

COBALAMIN; COBALT 57; COMPLEMENTARY DNA; MEMBRANE PROTEIN; MEMBRANE RECEPTOR; MESSENGER RNA; SMALL INTERFERING RNA; TRANSCOBALAMIN;

ARTICLE; CANCER CELL; CELL CULTURE; CELL CYCLE; CELL PROLIFERATION; CELL STRAIN HEK293; CONTROLLED STUDY; HUMAN; HUMAN CELL; ISOTOPE LABELING; PRIORITY JOURNAL; VITAMIN DEFICIENCY;

EID: 79956331144     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2011.02.016     Document Type: Article

References (26)

1. Cannata J.J., Focesi A., Mazumder R., Warner R.C., Ochoa S. Metabolism of propionic acid in animal tissues: XII. Properties of mammalian methylmalonyl coenzyme a mutase. J. Biol. Chem. 1965, 240:3249-3257.
2. Taylor R.T., Hanna L.M. Folate-dependent enzymes in cultured Chinese hamster ovary cells: induction of 5-methyltetrahydrofolate homocysteine cobalamin methyltransferase by folate and methionine. Arch. Biochem. Biophys. 1975, 171:507-520.
3. Green R. Metabolite assays in cobalamin and folate deficiency. Baillières Clin. Haematol. 1995, 8:533-566.
4. Tefferi A., Pruthi R.K. The biochemical basis of cobalamin deficiency. Mayo Clin. Proc. 1994, 69:181-186.
5. Quadros E.V., Rothenberg S.P., Jaffe E.A. Endothelial cells from human umbilical vein secrete functional transcobalamin II. Am. J. Physiol. 1989, 256:C296-C303.
6. Quadros E.V., Nakayama Y., Sequeira J.M. The binding properties of the human receptor for the cellular uptake of vitamin B12. Biochem. Biophys. Res. Commun. 2005, 327:1006-1010.
7. Quadros E.V., Nakayama Y., Sequeira J.M. The protein and the gene encoding the receptor for the cellular uptake of transcobalamin-bound cobalamin. Blood 2009, 113:186-192.
8. Hall C.A., Colligan P.D., Begley J.A. Cyclic activity of the receptors of cobalamin bound to transcobalamin II. J. Cell. Physiol. 1987, 133:187-191.
9. Amagasaki T., Green R., Jacobsen D.W. Expression of transcobalamin II receptors by human leukemia K562 and HL-60 cells. Blood 1990, 76:1380-1386.
10. Lindemans J., Kroes A.C., Van Geel J., Van Kapel J., Schoester M., Abels J. Uptake of transcobalamin II-bound cobalamin by HL-60 cells: effects of differentiation induction. Exp. Cell Res. 1989, 184:449-460.
11. McLean G.R., Quadros E.V., Rothenberg S.P., Morgan A.C., Schrader J.W., Ziltener H.J. Antibodies to transcobalamin II block in vitro proliferation of leukemic cells. Blood 1997, 89:235-242.
12. Battaglia-Hsu S.F., Akchiche N., Noel N., Alberto J.M., Jeannesson E., Orozco-Barrios C.E., Martinez-Fong D., Daval J.L., Gueant J.L. Vitamin B12 deficiency reduces proliferation and promotes differentiation of neuroblastoma cells and up-regulates PP2A, proNGF, and TACE. Proc. Natl Acad. Sci. 2009, 106:21930-21935.
13. Li L., Yoon S.O., Fu D.D., Zhang X., Choi Y.S. Novel follicular dendritic cell molecule, 8D6, collaborates with CD44 in supporting lymphomagenesis by a Burkitt lymphoma cell line, L3055. Blood 2004, 104:815-821.
14. Qian L., Quadros E.V., Rothenberg S.P. Molecular methods for analysis and expression of transcobalamin II. Meth. Enzymol. 1997, 281:269-281.
15. Jiang W., Sequeira J.M., Nakayama Y., Quadros E.V. Characterization of the promoter region of TCblR/CD320 gene, the receptor for cellular uptake of transcobalamin-bound cobalamin. Gene 2010, 466:49-55.
16. Russell-Jones G., McTavish K., McEwan J., Rice J., Nowotnik D. Vitamin-mediated targeting as a potential mechanism to increase drug uptake by tumors. J. Inorg. Biochem. 2004, 98:1625-1633.
17. Shane B., Stokstad E.L. Vitamin B12-folate interrelationships. Annu. Rev. Nutr. 1985, 5:115-141.
18. Bertino J.R. Cancer research: from folate antagonism to molecular targets. Best Pract. Res. Clin. Haematol. 2009, 22:577-582.
19. McGuire J.J. Anticancer antifolates: current status and future directions. Curr. Pharm. Des. 2003, 9:2593-2613.
20. Quadros E.V., Rothenberg S.P., McLoughlin P. Characterization of monoclonal antibodies to epitopes of human transcobalamin II. Biochem. Biophys. Res. Commun. 1996, 222:149-154.
21. Jiang W., Nakayama Y., Sequeira J.M., Quadros E.V. Characterizing monoclonal antibodies to antigenic domains of TCblR/CD320, the receptor for cellular uptake of transcobalamin-bound cobalamin. Drug Deliv. 2011, 1:74-78.
22. Quadros E.V., Nakayama Y., Sequeira J.M. Targeted delivery of saporin toxin by monoclonal antibody to the transcobalamin receptor, TCblR/CD320. Mol. Cancer Ther. 2010, 11:3033-3040.
23. Berliner N., Rosenberg L.E. Uptake and metabolism of free cyanocobalamin by cultured human fibroblasts from controls and a patient with transcobalamin II deficiency. Metabolism 1981, 30:230-236.
24. Ashihara E., Kawata E., Maekawa T. Future prospect of RNA interference for cancer therapies. Curr. Drug Targets 2010, 11:345-360.
25. Yan X., Chua M.S., He J., So S.K. Small interfering RNA targeting CDC25B inhibits liver tumor growth in vitro and in vivo. Mol. Cancer 2008, 7:19.
26. Shibata M.A., Morimoto J., Shibata E., Otsuki Y. Combination therapy with short interfering RNA vectors against VEGF-C and VEGF-A suppresses lymph node and lung metastasis in a mouse immunocompetent mammary cancer model. Cancer Gene Ther. 2008, 15:776-786.